Prevalence of Smoking and Impact on Disease Parameters Among Ankylosing Spondylitis, Rheumatoid Arthritis and Psoriatic Arthritis Patients Treated with Infliximab or Golimumab in Canada

被引：0

作者：

Faraawi, Rafat ^{[1
]}

Dixit, Sanjay ^{[2
]}

Mulgund, Manisha

Bensen, William ^{[2
]}

Kelsall, John ^{[3
]}

Choquette, Denis ^{[4
]}

Baker, Milton ^{[5
]}

Fortin, Isabelle ^{[6
]}

Sampalis, John ^{[7
]}

Rampakakis, Emmanouil ^{[7
]}

Nantel, Francois ^{[8
]}

Shawi, May ^{[8
]}

Lehman, Allen ^{[8
]}

Otawa, Susan ^{[8
]}

机构：

[1] McMaster Univ, Kitchener Waterloo, ON, Canada

[2] McMaster Univ, Hamilton, ON L8S 4L8, Canada

[3] Mary Pack Arthrit Ctr, Vancouver, BC, Canada

[4] Inst Rhumatol Montreal, Montreal, PQ, Canada

[5] Univ Victoria, Victoria, BC V8W 2Y2, Canada

[6] CH Rimouski, Rimouski, PQ, Canada

[7] JSS Med Res Inc, Montreal, PQ, Canada

[8] Janssen Inc, Toronto, ON, Canada

来源：

JOURNAL OF RHEUMATOLOGY | 2015年 / 42卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

178

引用

页码：1330 / 1331

页数：2

共 50 条

[1] PREVALENCE OF SMOKING AND IMPACT ON DISEASE PARAMETERS AMONG ANKYLOSING SPONDYLITIS, RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB OR GOLIMUMAB
Faraawi, R.
Dixit, S.
Mulgund, M.
Bensen, W.
Kelsall, J.
Choquette, D.
Baker, M.
Fortin, I.
Sampalis, J.
Rampakakis, E.
Tkaczyk, C.
Lehman, A.
Nantel, F.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1291 - 1292
[2] Golimumab In the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
Oldfield, Vicki
Plosker, Greg L.
BIODRUGS, 2009, 23 (02) : 125 - 135
[3] Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
Rossini, M.
Viapiana, O.
Orsolini, G.
Fracassi, E.
Idolazzi, L.
Gatti, D.
Adami, S.
Govoni, M.
REUMATISMO, 2014, 66 (04) : 285 - 303
[4] The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
Furst, Daniel E.
Kay, Jonathan
Wasko, Mary Chester
Keystone, Edward
Kavanaugh, Arthur
Deodhar, Atul
Murphy, Frederick T.
Magnus, Jeanette H.
Hsia, Elizabeth C.
Hsu, Benjamin
Xu, Stephen
Rahman, Mahboob U.
Doyle, Mittie K.
RHEUMATOLOGY, 2013, 52 (10) : 1845 - 1855
[5] PATIENT CHARACTERISTICS AND GOLIMUMAB UTILIZATION IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS PATIENTS
Tandon, N.
Haas, S.
Bolge, S.
Gunnarsson, C.
VALUE IN HEALTH, 2012, 15 (04) : A48 - A48
[6] Golimumab improves socio economic and health economic parameters in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
Krueger, Klaus
Burmester, Gerd Ruediger
Wassenberg, Siegfried
Thomas, Matthias H.
CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (09) : 1559 - 1567
[7] Golimumab: a guide to its use in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
Drugs & Therapy Perspectives, 2010, 26 (4) : 1 - 4
[8] Immunogenicity of golimumab and its clinical relevance in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
Leu, Jocelyn H.
Adedokun, Omoniyi J.
Gargano, Cynthia
Hsia, Elizabeth C.
Xu, Zhenhua
Shankar, Gopi
RHEUMATOLOGY, 2019, 58 (03) : 441 - 446
[9] GOLIMUMAB UTILIZATION PATTERNS AND REFILL ADHERENCE IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
Ellis, L.
Bolge, S.
Rice, P.
VALUE IN HEALTH, 2014, 17 (03) : A49 - A50
[10] GOLIMUMAB UTILIZATION PATTERNS AND REFILL ADHERENCE IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
Ellis, L.
Bolge, S.
Rice, P.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1154 - 1154

← 1 2 3 4 5 →